BOLT Acquisition: a positive outcome, +64.4%

On October 23, 2026, Bolt Biotherapeutics, Inc. reached its Acquisition. The result was a positive outcome, and the stock moved +64.4% in the window around the event. It had already run +18.1% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.